AstraZeneca: considering listing BU Vaccines

(CercleFinance.com) - Astrazeneca is reportedly considering listing its vaccines unit, which was created last November, Bloomberg reports.


Last month AstraZeneca's management announced the creation of a new division specialising in vaccines and immune therapies. The division is also in charge of a flu vaccine and a drug against RSV (respiratory syncytial virus).

At this stage, the group has not confirmed this project, Invest Securities says, however.



Copyright (c) 2021 CercleFinance.com. All rights reserved.